Disproportionate ventricular septal thickening occurred in 10% of patients with cardiac diseases, representing secondary hypertrophy rather than genetically transmitted asymmetric septal hypertrophy.
Cross-Sectional (n=304)
Echocardiographic and necropsy studies were performed in 304 patients with various cardiac diseases. The overall prevalence of disproportionate ventricular septal thickening (septal to free wall ratio greater than or equal to 1.3) was 10%. However, it was related to the type of cardiac lesion. Prevalence was high (greater than 20%) in pulmonary stenosis or primary pulmonary hypertension, lower (less than 15%) in Eisenmenger syndrome or aortic or mitral valvular disease and was not present in atrial or ventricular septal defect. In right ventricular overload, prevalence of disproportionate septal thickening correlated with increasing ventricular systolic pressure. None of 16 patients with disproportionate septal thickening studied at necropsy showed marked disorientation of cardiac muscle cells in the ventricular septum, characteristic of genetically transmitted asymmetric septal hypertrophy (ASH). Furthermore, disproportionate septal thickening was demonstrated by echocardiography in only one of 59 first degree relatives of patients with disproportionate septal thickening and associated cardiac diseases. Thus, disproportionate ventricular septal thickening associated with other cardiac diseases usually is due to secondary hypertrophy and is not a manifestation of genetically transmitted ASH.
Maron et al. (Tue,) conducted a cross-sectional in Acquired or congenital heart diseases (n=304). Acquired or congenital heart diseases was evaluated on Prevalence of disproportionate ventricular septal thickening (septal to free wall ratio ≥ 1.3). Disproportionate ventricular septal thickening occurred in 10% of patients with cardiac diseases, representing secondary hypertrophy rather than genetically transmitted asymmetric septal hypertrophy.